Prelude Capital Management’s Ambev ABEV Stock Holding History

Prelude Capital Management’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-4,800	Closed	-$26K	–	1584
2017 Q2	$26K	Buy	+4,800	New	+$27.4K	﹤0.01%	1197

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Prelude Capital Management's ABEV Position: Q1 2019 in Review

Prelude Capital Management sold out of Ambev (ABEV) in Q1 2019, closing a stake of 18,100 shares — an estimated $71K sold.

Prelude Capital Management first reported a position in ABEV in Q2 2017 and held it in 4 quarters. The position peaked at $71K in Q4 2018. 305 funds tracked by Wall St. Rank hold ABEV as of Q1 2019.

Prelude Capital Management reported no remaining Ambev position as of Q1 2019 after selling out during the quarter.
Prelude Capital Management sold 18,100 Ambev shares in Q1 2019, an estimated $71K.
Prelude Capital Management first reported a position in Ambev in Q2 2017 and held it in 4 quarters.
Prelude Capital Management's Ambev position peaked at $71K in Q4 2018.
305 funds tracked by Wall St. Rank held Ambev as of Q1 2019.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.